Aquarius Biotechnologies, a Chicago-based biotechnology company, specializes in the development of a unique drug delivery platform. Founded in 2013, the company focuses on improving existing drugs by leveraging its lipid-based delivery system. This platform shows promise in treating a range of infectious diseases. Aquarius Biotechnologies aims to revolutionize the field of biotechnology, medicine, and pharmaceuticals through its innovative approach to drug delivery.